The Jeonnam Bio Promotion Institute is expanding its collaboration with private companies to support the commercialization and market entry of local biohealthcare firms. The initiative aims to connect the technologies and products of companies still in the research and development phase with the branding and distribution capabilities of the private sector, creating tangible business opportunities.
On October 21, the Jeonnam Bio Promotion Institute's Green Bio Division Nano Center held a meeting with resident companies alongside the 'Sanga Life Science-Linked Biohealthcare Open Innovation' event.
This event was designed to explore the potential for joint product development and technology commercialization by linking the technologies and products held by resident companies with the research and development (R&D) needs, branding, and distribution capabilities of Sanga Life Science.
During the event, the Jeonnam Bio Promotion Institute signed a memorandum of understanding (MOU) with Sanga Life Science, IM Partners, and the IM Patent Law Firm to foster biohealthcare startups and build an open innovation ecosystem.
Under the agreement, the four organizations will collaborate on identifying promising biohealthcare startups, joint product development, technology commercialization, investment attraction, and securing intellectual property (IP) rights, among other areas essential for business growth.
The focus will be on enhancing the commercialization potential of resident companies' products by integrating the Nano Center's testing, analysis, prototype production, and manufacturing support infrastructure with the R&D needs and branding and distribution capabilities of private companies.
Plans are also in place to pursue follow-up commercialization collaborations, including joint research and technology transfer. However, specific joint development projects and investment amounts will be determined through future discussions among the institutions.
The event featured presentations on Sanga Life Science's R&D collaboration strategies and branding partnership models, as well as information on support programs from the Gwangju Research and Development Special Zone and basic tax education for startups.
Following the presentations, one-on-one roundtable meetings were held to assess the competitive edge of resident companies' technologies and products and discuss potential collaborations for joint development and market entry.
This collaboration is significant as it combines the strengths of public research support institutions and private companies, potentially providing new commercialization opportunities for local small and medium-sized enterprises that struggle with product commercialization and securing distribution networks.
The effectiveness of the collaborative framework that links R&D support, prototype production, IP acquisition, investment attraction, and market development will be closely monitored.
Moon Myung-jae, head of the Jeonnam Bio Promotion Institute's Nano Center, stated, "This event has created an opportunity to connect the excellent technologies and products of companies with the R&D needs and branding and distribution capabilities of the private sector. We will continue to seek collaboration opportunities that can lead to the commercialization and market entry of resident companies' technologies."
Meanwhile, open innovation is an approach where companies or research institutions combine their technologies and resources with the R&D capabilities and commercialization experience of external organizations to create new products and business opportunities. The Jeonnam Bio Promotion Institute's Nano Center plans to discover collaborative projects between resident companies and private enterprises and continue supporting subsequent technology commercialization efforts.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.